The store will not work correctly when cookies are disabled.
1-(chloromethyl)-4-(m-tolyl)-[1,2,4]triazolo[4,3-a]quinazolin-5(4H)-one
ID: ALA5287576
Max Phase: Preclinical
Molecular Formula: C17H13ClN4O
Molecular Weight: 324.77
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cccc(-n2c(=O)c3ccccc3n3c(CCl)nnc23)c1
Standard InChI: InChI=1S/C17H13ClN4O/c1-11-5-4-6-12(9-11)21-16(23)13-7-2-3-8-14(13)22-15(10-18)19-20-17(21)22/h2-9H,10H2,1H3
Standard InChI Key: XFGMROJZDLIFDN-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
1.7824 2.9451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7824 2.1201 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4986 1.7075 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4986 0.8865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7870 0.4701 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0694 0.8843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0694 1.7095 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3567 0.4718 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.3567 -0.3489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9784 -0.9160 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.6524 -1.6520 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.1715 -1.5647 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7549 -2.1482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5414 -2.9451 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-0.3548 -0.7656 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0724 -0.3515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0724 0.4734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7842 0.8853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4986 0.4730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4986 -0.3552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7824 -0.7632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3598 0.8843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3598 1.7093 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 2 0
4 3 1 0
5 4 2 0
6 5 1 0
7 6 2 0
2 7 1 0
8 6 1 0
9 8 1 0
9 10 2 0
10 11 1 0
12 11 2 0
12 13 1 0
13 14 1 0
15 12 1 0
15 9 1 0
16 15 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
17 22 1 0
8 22 1 0
22 23 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 324.77 | Molecular Weight (Monoisotopic): 324.0778 | AlogP: 3.08 | #Rotatable Bonds: 2 |
Polar Surface Area: 52.19 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.27 | CX LogD: 3.27 |
Aromatic Rings: 4 | Heavy Atoms: 23 | QED Weighted: 0.53 | Np Likeness Score: -1.84 |
References
1. Alagarsamy V, Chitra K, Saravanan G, Solomon VR, Sulthana MT, Narendhar B.. (2018) An overview of quinazolines: Pharmacological significance and recent developments., 151 [PMID:29656203] [10.1016/j.ejmech.2018.03.076] |